Siemens 2013 Annual Report Download - page 36


Providing high-quality medical technology
Improving healthcare

Fighting the most threatening diseases
Faster, more accurate
diagnosis reduces the risk of
life-threatening illness
Number of patients treated worldwide
using Siemens medical devices and lab tests

11 Based on the installed base of the Siemens products and solutions used to diagnose Based on the installed base of the Siemens products and solutions used to diagnose
and treat heart attack, stroke, HIV/AIDS, tuberculosis, breast cancer and lung cancer, and treat heart attack, stroke, HIV/AIDS, tuberculosis, breast cancer and lung cancer,
taking into account only those product categories included in the recommendations taking into account only those product categories included in the recommendations
of the relevant medical societies.of the relevant medical societies.
According to World Health Organization (WHO) statistics for the
year 2011, about 30% of all deaths due to illness are caused by car-
diovascular diseases, 15% by cancer and 15% by infection. Medical
products and solutions from Siemens are helping drive the fight
against these life-threatening illnesses. In 2013, for instance, our
healthcare devices and lab tests were used to examine or treat
more than 86 million victims of heart attack, stroke, breast cancer,
lung cancer, HIV/AIDS or tuberculosis. In 2014, we aim to help treat
more than 90 million people worldwide.
Our commitment is particularly clear in the area of HIV/AIDS. Africa
accounts for about 60% of the world’s HIV sufferers: about 22.5 mil-
lion of the continent’s inhabitants are currently infected with the
immunodeficiency virus. For rapid, effective therapy, early testing
is vital. And this is where Siemens comes in. In Africa, we’ve
equipped 18 laboratories in ten countries with lab tests and con-
ducted more than 350,000 examinations. Attending physicians use
the results to select and administer drug combinations tailored to
each patient. This example – just one of many – highlights the
major role that our clinical diagnostic tests are playing in the battle
against the world’s most dangerous diseases.
90 million treated patients Target
2014
86 million treated patients
Current
situation
2013
70 million treated patientstreated patients Starting
point
2010